These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 26223933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Meta-Analyses of Association Between BRAF(V600E) Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma.
    Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ, Zhu QY.
    Cell Physiol Biochem; 2016; 38(2):763-76. PubMed ID: 26871894
    [Abstract] [Full Text] [Related]

  • 3. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM.
    Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.
    PLoS One; 2016 Dec; 11(12):e0167414. PubMed ID: 27936049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.
    Li F, Chen G, Sheng C, Gusdon AM, Huang Y, Lv Z, Xu H, Xing M, Qu S.
    Endocr Relat Cancer; 2015 Apr; 22(2):159-68. PubMed ID: 25593071
    [Abstract] [Full Text] [Related]

  • 7. The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.
    Choi SY, Park H, Kang MK, Lee DK, Lee KD, Lee HS, Kim SW, Lee EN, Hong JC.
    World J Surg Oncol; 2013 Nov 14; 11():291. PubMed ID: 24228637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
    Li C, Lee KC, Schneider EB, Zeiger MA.
    J Clin Endocrinol Metab; 2012 Dec 14; 97(12):4559-70. PubMed ID: 23055546
    [Abstract] [Full Text] [Related]

  • 10. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
    Zhou YL, Zhang W, Gao EL, Dai XX, Yang H, Zhang XH, Wang OC.
    Asian Pac J Cancer Prev; 2012 Dec 14; 13(4):1267-72. PubMed ID: 22799316
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.
    Bernstein J, Virk RK, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman SA, Sosa JA, Prasad ML.
    Thyroid; 2013 Dec 14; 23(12):1525-31. PubMed ID: 23682579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.
    Park VY, Kim EK, Lee HS, Moon HJ, Yoon JH, Kwak JY.
    Medicine (Baltimore); 2015 Jul 14; 94(28):e1149. PubMed ID: 26181555
    [Abstract] [Full Text] [Related]

  • 17. Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.
    Attia AS, Hussein M, Issa PP, Elnahla A, Farhoud A, Magazine BM, Youssef MR, Aboueisha M, Shama M, Toraih E, Kandil E.
    Int J Mol Sci; 2022 Dec 09; 23(24):. PubMed ID: 36555268
    [Abstract] [Full Text] [Related]

  • 18. Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
    Moon S, Song YS, Kim YA, Lim JA, Cho SW, Moon JH, Hahn S, Park DJ, Park YJ.
    Thyroid; 2017 May 09; 27(5):651-660. PubMed ID: 28181854
    [Abstract] [Full Text] [Related]

  • 19. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.
    Virk RK, Van Dyke AL, Finkelstein A, Prasad A, Gibson J, Hui P, Theoharis CG, Carling T, Roman SA, Sosa JA, Udelsman R, Prasad ML.
    Mod Pathol; 2013 Jan 09; 26(1):62-70. PubMed ID: 22918165
    [Abstract] [Full Text] [Related]

  • 20. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.
    Li C, Aragon Han P, Lee KC, Lee LC, Fox AC, Beninato T, Thiess M, Dy BM, Sebo TJ, Thompson GB, Grant CS, Giordano TJ, Gauger PG, Doherty GM, Fahey TJ, Bishop J, Eshleman JR, Umbricht CB, Schneider EB, Zeiger MA.
    J Clin Endocrinol Metab; 2013 Sep 09; 98(9):3702-12. PubMed ID: 23969188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.